GAST and Atrophy: This may be achieved by the eradication of H. pylori before the occurrence of oxyntic atrophy, by avoiding the long-term use of drugs with profound inhibition of gastric acid secretion and by using gastrin antagonists when they become available, in those with autoimmune gastritis and in those with oxyntic atrophy due to previous H. pylori infection.